Anil Ranganath served as TransMedics' Senior Vice President, General Counsel and Corporate Secretary from June 2023 until March 9, 2026.
On the GC Transition Date he transitioned to a non-executive position and was succeeded by Matthew Forsyth; under a Transition Agreement dated February 3, 2026 he remained a non-executive employee until June 7, 2026 and then served as a non-employee consultant to the company until September 7, 2026.
Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.